Lymphatic filariasis elimination in Kenya: Tracing the journey from 2002-2024 and pathways to achieving 2030 target

Lymphatic filariasis (LF) is a neglected tropical disease that causes severe physical and psychological effects, such as elephantiasis and hydrocele, reducing quality of life and economic productivity. Kenya began its National Programme to Eliminate LF in 2000, with the first Mass Drug Administration (MDA) in 2002 in Kilifi, later expanding to other coastal counties. Despite early documentation of LF in 1910, MDA was inconsistent until 2015 due to limited resources. Since 2016, continuous MDA campaigns have significantly reduced disease prevalence. Kenya is now on track to eliminate LF as a public health problem by 2030

Read More>>